Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 100 publications
Ficerafusp Alfa (BCA101) With Pembrolizumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Two-Year Results of an Expansion Cohort of a Phase I/Ib Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 08, 2026
Deciphering T-cell exhaustion in the tumor microenvironment: paving the way for innovative solid tumor therapies.
Journal: Frontiers in immunology
Published: December 19, 2024
Publisher Correction: A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC.
Journal: Nature cancer
Published: January 10, 2024
Author Correction: A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC.
Journal: Nature cancer
Published: December 28, 2022
Changes in Circulating Tumor DNA Reflect Clinical Benefit Across Multiple Studies of Patients With Non-Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors.
Journal: JCO precision oncology
Published: August 11, 2022
A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC.
Journal: Nature cancer
Published: February 26, 2022
When Radiotherapy and Immunotherapy Dance-Who Leads So as Not to Step on Toes?
Journal: JAMA oncology
Published: January 06, 2022
Therapeutic Intervention Using a Smad7-Based Tat Protein to Treat Radiation-Induced Oral Mucositis.
Journal: International journal of radiation oncology, biology, physics
Published: June 28, 2021
The Clinical Cell-Cycle Risk (CCR) Score Is Associated With Metastasis After Radiation Therapy and Provides Guidance on When to Forgo Combined Androgen Deprivation Therapy With Dose-Escalated Radiation.
Journal: International journal of radiation oncology, biology, physics
Published: April 12, 2021
Distinct immune microenvironment profiles of therapeutic responders emerge in combined TGFβ/PD-L1 blockade-treated squamous cell carcinoma.
Journal: Communications biology
Published: October 27, 2020
Outcomes with durvalumab by tumour PD-L1 expression in unresectable, stage III non-small-cell lung cancer in the PACIFIC trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 02, 2020
Inhibiting Translation Elongation with SVC112 Suppresses Cancer Stem Cells and Inhibits Growth in Head and Neck Squamous Carcinoma.
Journal: Cancer research
Published: October 15, 2019
Last Updated: 09/26/2026